NDC 72301-595

Jeuveau

Prabotulinum Toxin Type A

Jeuveau is a Intramuscular Powder in the Human Prescription Drug category. It is labeled and distributed by Evolus, Inc.. The primary component is Botulinum Toxin Type A.

• Product ID: 72301-595_2ca5b2df-12ce-48f2-b446-f9a69f923539
• NDC: 72301-595
• Product Type: Human Prescription Drug
• Proprietary Name: Jeuveau
• Generic Name: Prabotulinum Toxin Type A
• Dosage Form: Powder
• Route of Administration: INTRAMUSCULAR
• Marketing Start Date: 2019-02-13
• Marketing Category: BLA / BLA
• Application Number: BLA761085
• Labeler Name: Evolus, Inc.
• Substance Name: BOTULINUM TOXIN TYPE A
• Active Ingredient Strength: 100 [USP'U]/1
• Pharm Classes: Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 72301-595-10

1 VIAL in 1 CARTON (72301-595-10) > 1 POWDER in 1 VIAL

• Marketing Start Date: 2019-02-13
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72301-595-10 [72301059510]

Jeuveau POWDER

• Marketing Category: BLA
• Application Number: BLA761085
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2019-02-13

Drug Details

Active Ingredients

Ingredient	Strength
BOTULINUM TOXIN TYPE A	100 [USP'U]/1

OpenFDA Data

• SPL SET ID: 17a914c1-e54b-4b50-965d-b0fd9111bba4
• Manufacturer:
  • Evolus, Inc.
• UNII:
  • E211KPY694
• RxNorm Concept Unique ID - RxCUI:
  • 2117871
  • 2117876

Pharmacological Class

• Acetylcholine Release Inhibitor [EPC]
• Acetylcholine Release Inhibitors [MoA]